Published Online: Friday, February 1, 2008

The FDA recently made its first ruling on OTC cough and cold medicines for babies and toddlers—avoid these drugs for children under age 2 "because serious and potentially life-threatening side effects can occur."

The issue surrounding cold remedies and young children heated up last October when drug companies stopped selling versions of medicines specifically targeted to babies and toddlers. At the same time, the FDA's own scientific advisers voted that the medications are not effective in small children and should not be used in children under age 6. The public health advisory was issued because the agency is concerned that parents have not gotten the message despite all the media coverage.

Still on the table is whether the remedies are safe and effective for children under age 12. Last fall, the agency's advisers did not recommend that children aged 6 to 11 stop using the medications. The group did, however, call for additional research to determine what effects the remedies have in youngsters overall. Meanwhile, an internal FDA group has not reached a consensus regarding children aged 2 to 11 years.

This month is the deadline to send recommendations to agency leaders, according to Charles Ganley, MD, directo r of the Office of Nonprescription Products at the FDA's Center for Drug Evaluation and Research. The FDA said to expect a decision by spring.

Latest Articles
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Latest Issues